Digital Health Startups

LUBU makes smart insoles with built-in sensors that capture movement biomechanics and kinetic data to predict injury and track recovery for athletes, military personnel, and patients. The company uses proprietary hardware and AI-driven analysis, drawing on seventy years of footwear manufacturing expertise, to provide lab-grade movement measurement at scale.

1 investor

Luca Healthcare develops AI-driven digital medicine products built around digital biomarkers and digital clinical endpoints, providing digital endpoint technology to improve the efficiency and lower the cost of clinical trials for life sciences companies. Its health technology also embeds into wellness and consumer health solutions, offering remote and home-based care and disease risk assessment across prevention, screening, intervention, and recovery.

1 investor

Lucea provides AI-powered triage software that pairs automation with clinical intelligence to support clinicians during pediatric triage calls, offering protocol-aligned context while clinicians retain clinical judgment. It is built for pediatric practices and their care teams, focusing on more efficient and consistent triage workflows.

1 investor

Lucem Health applies clinical artificial intelligence to help healthcare providers detect chronic diseases earlier in patients. The company develops AI-driven platforms for healthcare systems to improve disease detection and patient outcomes.

1 investor

Lucence develops blood-based diagnostic tests for early cancer detection, hereditary and health risk assessment, treatment selection, and treatment response monitoring. Its liquid biopsy and tissue tests serve oncology patients and clinicians across multiple solid tumors and hematological cancers, available internationally and in the USA.

1 investor

Lucent Health provides health benefits administration for self-insured employers, combining claims management with data-driven, human-focused care management to help health plan participants make cost-saving healthcare decisions. The company operates nationwide in the US.

1 investor

Lucid Diagnostics develops tests for the early detection of esophageal precancer using targeted next-generation sequencing, aimed at helping clinicians detect and treat the condition before it progresses to cancer. The company operates a CLIA-certified, CAP-accredited clinical lab licensed by the New York State Department of Health.

1 investor

Lucid Genomics provides a software platform for genomic analysis tailored to clinicians, specializing in long-read sequencing interpretation for rare disease, hereditary cancer, and pharmacogenomics diagnostics. The platform integrates variant calling, prioritization, interpretation, and reporting with HPO-based phenotype matching and advanced visualization tools for structural variants.

1 investor

LucidHealth is a physician-led healthcare organization that supports a national network of radiology practices across the United States through corporate services including operations, finance, technology, and strategy. The company focuses on empowering radiologists and advancing clinical outcomes in radiology care.

1 investor

Ludocare develops digital therapeutics for pediatric asthma management, combining an interactive health companion app for children with a parental app for monitoring and treatment optimization. The company targets healthcare systems and pediatricians in France seeking to improve asthma control and medication adherence in children ages 4-11.

1 investor

Lumara provides AI agents that automate administrative tasks for healthcare organizations, helping health plans, digital health companies, and other healthcare ecosystem players reduce operational costs while improving member engagement and experience.

1 investor

Lume develops a wearable sweat sensor that monitors hormonal changes and health metrics throughout the day. The device is designed for individuals seeking continuous health insights beyond traditional periodic checkups.

1 investor

InvolveXR offers an AI-enabled virtual reality training platform for healthcare education that combines immersive simulations with AI-assisted assessments to help institutions scale personalized learning and clinical skill development.

1 investor

Lumia Care operates a healthcare conglomerate that provides aged care, disability support, hospital-level in-home care, and nursing workforce services across Australia. The company serves individuals, families, and healthcare institutions seeking personalized and clinical care services to support independence and wellbeing.

1 investor

Luminoah is a medical technology company developing a connected enteral nutrition (tube feeding) system that combines a compact smart pump with a mobile app to track feeding data. Its products serve individuals who rely on tube feeding, along with their caregivers and clinicians.

1 investor

Lumonus builds an AI-powered oncology intelligence layer that acts as a workflow assistant for radiation oncology teams, integrating with major EMR, OIS, and TPS systems. Its products cover learning, automation, and knowledge management to speed up processes such as contouring and treatment planning while reducing errors.

1 investor

Lumos Diagnostics develops rapid point-of-care diagnostic tests and digital reader platforms for healthcare professionals, targeting infectious and inflammatory diseases. The company offers both customized assay development services and proprietary branded diagnostic solutions.

1 investor

Luna is a home-based physical therapy service that connects patients with licensed physical therapists for in-person treatment at their home or workplace, supported by an app for exercise prescription and communication between sessions.

1 investor

Lunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables. The device, currently under investigation, includes a stimulation lead, pulse generator, and titration lead to support automated therapy adjustment and patient management.

1 investor

Lunalta develops an AI-powered platform for perimenopause and menopause care, connecting women with personalized health guidance and qualified healthcare providers. The platform delivers 24/7 support through AI agents accessible via text and voice across iOS, Android, and web.

1 investor

Lura Health develops a wearable saliva-based health monitor that integrates micro sensors into dental hardware such as aligners or attaches to a tooth to continually track biomarkers like glucose and electrolytes. The device sends data to a smartphone app and to doctors to support monitoring of chronic conditions such as diabetes and hypertension.

1 investor

Luuze is a weight-loss and weight-tracking mobile app for iOS and Android that calculates a smoothed "trend weight" to filter out daily scale fluctuations and show real progress. It offers goal recommendations, smart scale syncing (Fitbit, Withings, Apple Health), note recording, reminders, and virtual coaching for individuals trying to lose or maintain weight.</parameter> <parameter name="founders">[{"full_name": "Andrew"}]

1 investor

LUX Infusion provides clinical infusion therapy for patients with complex and chronic conditions, including immune deficiencies, autoimmune and inflammatory conditions, transplant immunosuppression, and bleeding disorders. It delivers care at home or at its infusion locations and manages insurance approvals, prior authorizations, and medication delivery for patients.

1 investor

LUX MED operates a network of private medical facilities in Poland, offering diagnostic imaging (MRI, CT, mammography, ultrasound, X-ray), laboratory testing, specialist physician consultations, and optical salons. It serves patients seeking outpatient healthcare and provides urgent medical assistance around the clock.

1 investor